Discontinued — last reported Q2 '23
Business Segments · Sales to customers
Pharmaceutical — Sales to customers
Johnson & Johnson Pharmaceutical — Sales to customers increased by 2.4% to $13.73B in Q2 2023 compared to the prior quarter. Year-over-year, this metric grew by 3.1%, from $13.32B to $13.73B. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
StatementSegment
CategoryGrowth
SignalHigher is better
VolatilityStable
First reportedQ1 2009
Last reportedQ2 2023
How to read this metric
Higher sales indicate strong market adoption and effective commercial execution, while declining sales may signal patent cliffs or increased competition.
Detailed definition
This metric measures the total net revenue generated from the sale of pharmaceutical products to external customers. It...
Peer comparison
Standard metric across all pharmaceutical companies, often labeled as 'Segment Revenue' or 'Net Sales'.
Metric ID:
jnj_segment_pharmaceutical_sales_to_customersHistorical Data
9 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | |
|---|---|---|---|---|---|---|---|---|---|
| Value | $12.60B | $12.99B | $14.29B | $12.87B | $13.32B | $13.21B | $13.16B | $13.41B | $13.73B |
| QoQ Change | — | +3.1% | +10.0% | -9.9% | +3.5% | -0.8% | -0.4% | +1.9% | +2.4% |
| YoY Change | — | — | — | — | +5.7% | +1.7% | -7.9% | +4.2% | +3.1% |
Range$12.60B – $14.29B
CAGR+4.4%
Avg YoY Growth+1.4%
Median YoY Growth+3.1%
Current Streak2 quarters growth
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Johnson & Johnson's pharmaceutical — sales to customers?
- Johnson & Johnson (JNJ) reported pharmaceutical — sales to customers of $13.73B in Q2 2023.
- How has Johnson & Johnson's pharmaceutical — sales to customers changed year-over-year?
- Johnson & Johnson's pharmaceutical — sales to customers increased by 3.1% year-over-year, from $13.32B to $13.73B.
- What does pharmaceutical — sales to customers mean?
- Total net revenue earned from selling pharmaceutical products to customers.